Latest Ingelheim am Rhein Stories
FRENCHS FOREST, Australia and INGELHEIM, Germany, May 18, 2015 /PRNewswire/ -- -- Boehringer Ingelheim exercises option and acquires global ownership of Pharmaxis'
RIDGEFIELD, Conn., and SACRAMENTO, Calif., May 11, 2015 /PRNewswire/ -- Boehringer Ingelheim, a family-owned biopharmaceutical company, and Sutter Health, a not-for-profit health system in Northern
BOCA RATON, Fla., March 12, 2015 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for dabigatran etexilate
Spanish-Language Resources Encourage Holding On to the Gift of Health RIDGEFIELD, Conn., Feb. 10, 2015 /PRNewswire/ -- Today, Boehringer Ingelheim Pharmaceuticals, Inc.
Redesigned Bi-vetmedica.com Features Mobile-ready Options, Online Research and Catalog of Scientific Publications by Knowledge Leaders ST. JOSEPH, Mo., Feb.
DiabetesSisters has received joint funding from Boehringer-Ingelheim and Eli Lilly in the amount of $50,0000 to support the creation of DiabetesSisters’ first Educational Library.
HEIDELBERG, Germany, January 5, 2015 /PRNewswire/ -- BioMed X announced today that they have entered into a collaboration agreement with Boehringer Ingelheim to establish
Significant portion of alliance opportunity will remain unchanged; some countries will transition to exclusive promotion in 2015 INDIANAPOLIS and INGELHEIM, Germany, Oct.
LONDON and BOSTON, October 28, 2014 /PRNewswire/ -- Global top 20 pharma company streamlines R&D IT with cross-domain platform Boehringer Ingelheim,
BONN, Germany, October 14, 2014 /PRNewswire/ -- Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer
- A young chicken: also used as a pet name for children.